348 related articles for article (PubMed ID: 32139705)
1. MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7.
Liu ZQ; Ren JJ; Zhao JL; Zang J; Long QF; Du JJ; Jia XT; Gu NB; Di ZL; Qian YH; Li SZ
Sci Rep; 2020 Mar; 10(1):4155. PubMed ID: 32139705
[TBL] [Abstract][Full Text] [Related]
2. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
Ma S; Fu T; Zhao S; Gao M
Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
[TBL] [Abstract][Full Text] [Related]
5. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
6. miR-4530 inhibits the malignant biological behaviors of human glioma cells by directly targeting RTEL1.
Wang T; Zhang Y; Cui B; Wang M; Li Y; Gao K
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1394-1403. PubMed ID: 33200790
[TBL] [Abstract][Full Text] [Related]
7. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-6807-3p promotes the tumorigenesis of glioma by targeting downstream DACH1.
Lu GF; Geng F; Xiao Z; Chen YS; Han Y; You CY; Gong NL; Xie ZM; Pan M
Brain Res; 2019 Apr; 1708():47-57. PubMed ID: 30527681
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of MicroRNA-216a Suppresses Proliferation, Migration, and Invasion of Glioma Cells by Targeting Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5.
Zhang J; Xu K; Shi L; Zhang L; Zhao Z; Xu H; Liang F; Li H; Zhao Y; Xu X; Tian Y
Oncol Res; 2017 Sep; 25(8):1317-1327. PubMed ID: 28256193
[TBL] [Abstract][Full Text] [Related]
10. miR-381-3p restrains cervical cancer progression by downregulating FGF7.
Shang A; Zhou C; Bian G; Chen W; Lu W; Wang W; Li D
J Cell Biochem; 2019 Jan; 120(1):778-789. PubMed ID: 30161290
[TBL] [Abstract][Full Text] [Related]
11. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway.
Zhang L; Wang Y; Su H
Neoplasma; 2020 Jul; 67(4):762-772. PubMed ID: 32726126
[TBL] [Abstract][Full Text] [Related]
13. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2.
Zhang X; Yu J; Zhao C; Ren H; Yuan Z; Zhang B; Zhuang J; Wang J; Feng B
Biomed Pharmacother; 2019 Jan; 109():2192-2202. PubMed ID: 30551476
[TBL] [Abstract][Full Text] [Related]
14. Suppression of microRNA-130b inhibits glioma cell proliferation and invasion, and induces apoptosis by PTEN/AKT signaling.
Gu JJ; Fan KC; Zhang JH; Chen HJ; Wang SS
Int J Mol Med; 2018 Jan; 41(1):284-292. PubMed ID: 29115407
[TBL] [Abstract][Full Text] [Related]
15. miR-548b inhibits the proliferation and invasion of malignant gliomas by targeting metastasis tumor-associated protein-2.
Pan Y; Liang W; Zhao X; Liu L; Qing Y; Li Y
Neuroreport; 2016 Dec; 27(17):1266-1273. PubMed ID: 27682888
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
Xu JX; Yang Y; Zhang X; Luan XP
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas.
He J; Huang Z; He M; Liao J; Zhang Q; Wang S; Xie L; Ouyang L; Koeffler HP; Yin D; Liu A
Mol Cancer; 2020 Jan; 19(1):17. PubMed ID: 31992303
[TBL] [Abstract][Full Text] [Related]
18. Silencing of lncRNA CCDC26 Restrains the Growth and Migration of Glioma Cells In Vitro and In Vivo via Targeting miR-203.
Wang S; Hui Y; Li X; Jia Q
Oncol Res; 2018 Sep; 26(8):1143-1154. PubMed ID: 28600863
[TBL] [Abstract][Full Text] [Related]
19. MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway.
Zhang J; Liu WL; Zhang L; Ge R; He F; Gao TY; Tian Q; Mu X; Chen LH; Chen W; Li X
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):50-57. PubMed ID: 30213289
[TBL] [Abstract][Full Text] [Related]
20. MiR-199a-3p inhibits the proliferation, migration, and invasion of endothelial cells and retinal pericytes of diabetic retinopathy rats through regulating FGF7 via EGFR/PI3K/AKT pathway.
Zhou L; Zhang S; Zhang L; Li F; Sun H; Feng J
J Recept Signal Transduct Res; 2021 Feb; 41(1):19-31. PubMed ID: 32586178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
